Steps being taken to minimize the environmental impacts of PIE include: conducting Environmental Risk Assessments for all new drug compounds; collecting environmental risk assessment data for all major pharmaceutical products, including a prioritized list of legacy products; working with others in industry, academia and other non-governmental organizations to further the scientific research to achieve a better understanding of this issue; working closely with regulatory and environmental agencies to ensure that the potential impacts of pharmaceuticals on human health and on the aquatic environment are understood and minimized; and partnering with a wide range of stakeholder groups that share our commitment to safeguarding the environment based on sound science and effective actions.